Low prevalence of epilepsy and onchocerciasis after more than 20years of ivermectin treatment in the Imo River Basin in Nigeria

被引:22
|
作者
Siewe, Joseph N. F. [1 ]
Ukaga, Chinyere N. [2 ]
Nwazor, Ernest O. [3 ,4 ]
Nwoke, Murphy O. [2 ]
Nwokeji, Modebelu C. [2 ]
Onuoha, Blessing C. [2 ]
Nwanjor, Simon O. [2 ]
Okeke, Joel [5 ]
Osahor, Kate [2 ]
Chimechefulam, Lilian [2 ]
Ogomaka, Ann I. [2 ]
Amaechi, Augustine A. [2 ]
Ezenwa, Chika I. [2 ]
Ezike, Monika N. [2 ]
Ikpeama, Chidimma [2 ]
Nwachukwu, Ogechi [2 ]
Eriama-Joseph, Austine I. [2 ]
Nwoke, Berthram E. B. [2 ]
Colebunders, Robert [1 ]
机构
[1] Univ Antwerp, Global Hlth Inst, Campus Drie Eiken,Doornstr 331, B-2610 Antwerp, Belgium
[2] Imo State Univ, Owerri, Nigeria
[3] Fed Med Ctr, Owerri, Nigeria
[4] Madonna Univ Teaching Hosp, Elele, Nigeria
[5] Imo State Minist Hlth, Owerri, Nigeria
基金
欧洲研究理事会;
关键词
Epilepsy; Onchocerciasis; Nigeria; Ivermectin; Ov16; NODDING SYNDROME;
D O I
10.1186/s40249-019-0517-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundHigh epilepsy prevalence and incidence have been reported in areas with high onchocerciasis transmission. Recent findings suggest that proper community-directed treatment with ivermectin (CDTI) is potentially able to prevent onchocerciasis-associated epilepsy (OAE). We assessed the epilepsy prevalence and onchocerciasis transmission in two Nigerian villages following more than 20years of CDTI.MethodsA cross-sectional door-to-door survey was performed in two villages in the Imo River Basin reported to be mesoendomic for onchocerciasis (Umuoparaodu and Umuezeala). Individuals were screened for epilepsy using a validated 5-item questionnaire. Persons suspected to have epilepsy were examined by a neurologist or a physician with training in epilepsy for confirmation. Onchocerciasis was investigated via skin snip microscopy and rapid diagnostic tests for Ov16 antibodies. Results were compared with previous findings from the Imo river basin.ResultsA total of 843 individuals from 257 households in the two villages were encountered. We detected four persons with epilepsy (PWE) giving a crude epilepsy prevalence of 0.5%. This finding differs from observations reported 14years ago which showed an epilepsy prevalence of 2.8% in the neighbouring village of Umulolo (P=0.0001), and 1.2% from 13 villages in the Imo river basin (P=0.07). The seroprevalence of Ov16 antibodies was found to be 0%. Only 4.6% of skin snips were positive compared to 26.8% in previous surveys (P<0.0001). Ivermectin mass distribution coverage in the study sites in 2017 was 79.7%.ConclusionsA low epilepsy and onchocerciasis prevalence was observed following more than 20years of CDTI in the Imo River Basin. Absence of Ov16 antibodies indicates minimal transmission of onchocerciasis. These results contrast with observations from areas of high onchocerciasis transmission, where epilepsy prevalence and incidence remain high. Findings from this study suggest that sustained efforts could eventually achieve elimination of onchocerciasis in these villages.
引用
收藏
页数:9
相关论文
共 47 条
  • [41] Low-dose anthracyclines in childhood Acute Lymphoblastic Leukemia (ALL): No cardiac deterioration more than 20 years post-treatment
    Brouwer C.A.J.
    Gietema J.A.
    Van Den Berg M.P.
    Bink-Boelkens M.T.E.
    Elzenga N.J.
    Haaksma J.
    Kamps W.A.
    Vonk J.M.
    Postma A.
    Journal of Cancer Survivorship, 2007, 1 (4) : 255 - 260
  • [42] Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
    Stelwagen, Johannes
    Lubberts, Sjoukje
    Steggink, Lars C.
    Steursma, Gerrie
    Kruyt, Lara M.
    Donkerbroek, Jan Willem
    van Roon, Arie M.
    van Gessel, Anne I.
    van de Zande, Saskia C.
    Meijer, Coby
    Grafin zu Eulenburg, Christine H.
    Oosting, Sjoukje F.
    Nuver, Janine
    Walenkamp, Annemiek M. E.
    Jan de Jong, Igle
    Lefrandt, Joop D.
    Gietema, Jourik A.
    BRITISH JOURNAL OF CANCER, 2020, 123 (11) : 1599 - 1607
  • [43] Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
    Johannes Stelwagen
    Sjoukje Lubberts
    Lars C. Steggink
    Gerrie Steursma
    Lara M. Kruyt
    Jan Willem Donkerbroek
    Arie M. van Roon
    Anne I. van Gessel
    Saskia C. van de Zande
    Coby Meijer
    Christine H. Gräfin zu Eulenburg
    Sjoukje F. Oosting
    Janine Nuver
    Annemiek M. E. Walenkamp
    Igle Jan de Jong
    Joop D. Lefrandt
    Jourik A. Gietema
    British Journal of Cancer, 2020, 123 : 1599 - 1607
  • [44] Re: Vascular Aging in Long-Term Survivors of Testicular Cancer More than 20 Years after Treatment with Cisplatin-Based Chemotherapy
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2022, 207 (02): : 470 - 470
  • [45] Transmission of Risk-Group Specific HIV-1 Strains Among Dutch Drug Users for More Than 20 Years and Their Replacement by Nonspecific Strains After Switching to Low-Harm Drug Practices
    Lukashov, Vladimir V.
    Jurriaans, Suzanne
    Bakker, Margreet
    Berkhout, Ben
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (02) : 234 - 238
  • [46] A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin In Elderly (75 years or more) and Younger (less than 75 years) Patients: Results of a Posted Analysis of 5559 Patients
    Feldman, R.
    Flack, J.
    Hobbs, R.
    Howes, L.
    Jenssen, T.
    Reeves, R.
    Shi, H.
    Westergaard, M.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 : 12 - 12
  • [47] A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin in Younger (Less Than 65 Years) and Older (65 Years or More) Men and Women Results of a Pooled Analysis of 5559 Patients
    Hobbs, R.
    Feldman, R.
    Flack, J.
    Howes, L.
    Jenssen, T.
    Reeves, R.
    Shi, H.
    Westergaard, M.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 : 13 - 13